Drug Shortage Report for PRAXBIND
| Report ID | 65540 |
| Drug Identification Number | 02454343 |
| Brand name | PRAXBIND |
| Common or Proper name | Praxbind |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | IDARUCIZUMAB |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 2 x 50ml |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-24 |
| Estimated end date | 2018-11-16 |
| Actual end date | 2018-11-06 |
| Shortage status | Resolved |
| Updated date | 2018-11-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-11-07 | English | Compare |
| v5 | 2018-11-06 | French | Compare |
| v4 | 2018-11-06 | English | Compare |
| v3 | 2018-10-25 | English | Compare |
| v2 | 2018-10-24 | French | Compare |
| v1 | 2018-10-24 | English | Compare |
Showing 1 to 6 of 6